Search Results - Wikén, Margareta

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Development and effect of antibodies to anakinra during treatment of severe CAPS: sub-analysis of a long-term safety and efficacy study

    Development and effect of antibodies to anakinra during treatment of severe CAPS: sub-analysis of a long-term safety and efficacy study by Wikén, Margareta, Hallén, Bengt, Kullenberg, Torbjörn, Koskinen, Lisa Osterling

    Published in Clinical rheumatology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Real‐world assay variability between laboratories in monitoring of recombinant factor IX Fc fusion protein activity in plasma samples

    Real‐world assay variability between laboratories in monitoring of recombinant factor IX Fc fusion protein activity in plasma samples by Sommer, Jurg M., Sadeghi‐Khomami, Ali, Barnowski, Christopher, Wikén, Margareta, Willemze, Annemieke J.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares

    A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares by Saag, Kenneth G., Khanna, Puja P., Keenan, Robert T., Ohlman, Sven, Osterling Koskinen, Lisa, Sparve, Erik, Åkerblad, Ann‐Charlotte, Wikén, Margareta, So, Alexander, Pillinger, Michael H., Terkeltaub, Robert

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Chemically modified recombinant human sulfamidase (SOBI003) in mucopolysaccharidosis IIIA patients: Results from an open, non-controlled, multicenter study

    Chemically modified recombinant human sulfamidase (SOBI003) in mucopolysaccharidosis IIIA patients: Results from an open, non-controlled, multicenter study by Harmatz, Paul, Muenzer, Joseph, Ezgü, Fatih, Dalén, Per, Huledal, Gunilla, Lindqvist, Daniel, Gelius, Stefan Svensson, Wikén, Margareta, Önnestam, Kristin, Bröijersén, Anders

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Safety and tolerability of SOBI003 in pediatric MPS IIIA patients - key study design features of the ongoing first-in-human study

    Safety and tolerability of SOBI003 in pediatric MPS IIIA patients - key study design features of the ongoing first-in-human study by Bröijersén, Anders, Dalén, Per, Ezgü, Fatih, Huledal, Gunilla, Lindqvist, Daniel, Wikén, Margareta, Harmatz, Paul

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic use

    Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic use by Frandsen, Torben P., Næsted, Henrik, Rasmussen, Søren K., Hauptig, Peter, Wiberg, Finn C., Rasmussen, Lone Kjær, Jensen, Anne Marie Valentin, Persson, Pia, Wikén, Margareta, Engström, Anders, Jiang, Yun, Thorpe, Susan J., Förberg, Cecilia, Tolstrup, Anne B.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Ageing before Mating and Quinacrine Ameliorate the Expression of Abnormal Oocyte (abo) in Homozygous Drosophila Melanogaster Females

    Ageing before Mating and Quinacrine Ameliorate the Expression of Abnormal Oocyte (abo) in Homozygous Drosophila Melanogaster Females by Önfelt, Agneta, Magnusson, Jan, Wikén, Margareta

    Published in Hereditas
    Request full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: